Edgewise Therapeutics (EWTX) Competitors $12.98 +0.16 (+1.25%) As of 09:58 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EWTX vs. TLX, TGTX, LNTH, NUVL, AXSM, AKRO, PCVX, ADMA, PTCT, and RYTMShould you be buying Edgewise Therapeutics stock or one of its competitors? The main competitors of Edgewise Therapeutics include Telix Pharmaceuticals (TLX), TG Therapeutics (TGTX), Lantheus (LNTH), Nuvalent (NUVL), Axsome Therapeutics (AXSM), Akero Therapeutics (AKRO), Vaxcyte (PCVX), ADMA Biologics (ADMA), PTC Therapeutics (PTCT), and Rhythm Pharmaceuticals (RYTM). These companies are all part of the "pharmaceutical products" industry. Edgewise Therapeutics vs. Its Competitors Telix Pharmaceuticals TG Therapeutics Lantheus Nuvalent Axsome Therapeutics Akero Therapeutics Vaxcyte ADMA Biologics PTC Therapeutics Rhythm Pharmaceuticals Edgewise Therapeutics (NASDAQ:EWTX) and Telix Pharmaceuticals (NASDAQ:TLX) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, valuation, institutional ownership, media sentiment, profitability and dividends. Does the media favor EWTX or TLX? In the previous week, Edgewise Therapeutics had 13 more articles in the media than Telix Pharmaceuticals. MarketBeat recorded 17 mentions for Edgewise Therapeutics and 4 mentions for Telix Pharmaceuticals. Telix Pharmaceuticals' average media sentiment score of 0.80 beat Edgewise Therapeutics' score of 0.46 indicating that Telix Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edgewise Therapeutics 4 Very Positive mention(s) 1 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Telix Pharmaceuticals 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation and earnings, EWTX or TLX? Telix Pharmaceuticals has higher revenue and earnings than Edgewise Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEdgewise TherapeuticsN/AN/A-$133.81M-$1.55-8.37Telix Pharmaceuticals$516.72M10.63$32.93MN/AN/A Do analysts prefer EWTX or TLX? Edgewise Therapeutics currently has a consensus price target of $40.00, suggesting a potential upside of 208.17%. Telix Pharmaceuticals has a consensus price target of $22.00, suggesting a potential upside of 35.47%. Given Edgewise Therapeutics' higher possible upside, research analysts clearly believe Edgewise Therapeutics is more favorable than Telix Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Edgewise Therapeutics 0 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.80Telix Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is EWTX or TLX more profitable? Telix Pharmaceuticals' return on equity of 0.00% beat Edgewise Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Edgewise TherapeuticsN/A -30.95% -29.45% Telix Pharmaceuticals N/A N/A N/A SummaryTelix Pharmaceuticals beats Edgewise Therapeutics on 6 of the 9 factors compared between the two stocks. Get Edgewise Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EWTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EWTX vs. The Competition Export to ExcelMetricEdgewise TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.37B$2.85B$5.48B$8.94BDividend YieldN/A2.69%5.38%4.12%P/E Ratio-8.4121.1726.2219.74Price / SalesN/A262.85394.92109.12Price / CashN/A41.8936.4957.06Price / Book2.687.237.915.37Net Income-$133.81M-$55.05M$3.15B$248.34M7 Day Performance-9.42%-0.60%0.75%1.67%1 Month Performance-11.64%3.77%3.46%4.56%1 Year Performance-29.38%2.20%34.60%18.42% Edgewise Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EWTXEdgewise Therapeutics2.6282 of 5 stars$12.98+1.2%$40.00+208.2%-33.8%$1.37BN/A-8.4160Analyst ForecastAnalyst RevisionTLXTelix PharmaceuticalsN/A$16.39-4.4%$22.00+34.2%N/A$5.80B$516.72M0.00N/AGap DownHigh Trading VolumeTGTXTG Therapeutics3.7601 of 5 stars$36.56+1.5%$40.80+11.6%+95.0%$5.72B$329M152.33290LNTHLantheus4.3359 of 5 stars$80.81+2.0%$130.50+61.5%-0.7%$5.48B$1.53B22.96700NUVLNuvalent3.6299 of 5 stars$75.98+1.3%$115.50+52.0%+3.3%$5.39BN/A-17.3140Insider TradeAXSMAxsome Therapeutics4.7553 of 5 stars$101.65+1.0%$172.33+69.5%+27.1%$4.96B$385.69M-17.62380Positive NewsAnalyst RevisionAKROAkero Therapeutics3.5685 of 5 stars$54.03-0.3%$82.50+52.7%+122.0%$4.32BN/A-27.7130PCVXVaxcyte1.8849 of 5 stars$33.25+1.2%$136.50+310.5%-57.2%$4.24BN/A-8.33160News CoveragePositive NewsADMAADMA Biologics4.078 of 5 stars$17.87+0.7%$27.67+54.8%+54.8%$4.24B$426.45M21.02530PTCTPTC Therapeutics4.347 of 5 stars$49.60-1.2%$65.00+31.0%+55.9%$3.98B$806.78M7.621,410Analyst RevisionRYTMRhythm Pharmaceuticals3.9005 of 5 stars$62.13+0.2%$76.62+23.3%+53.4%$3.94B$130.13M-22.11140 Related Companies and Tools Related Companies Telix Pharmaceuticals Competitors TG Therapeutics Competitors Lantheus Competitors Nuvalent Competitors Axsome Therapeutics Competitors Akero Therapeutics Competitors Vaxcyte Competitors ADMA Biologics Competitors PTC Therapeutics Competitors Rhythm Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EWTX) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edgewise Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edgewise Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EWTX Stock Alerts